Data Insights
No Filter Selected
No Filter Selected
No Filter Selected
No Filter Selected
Olokizumab by R-Pharm for Sarcoidosis: Likelihood of Approval
Olokizumab is under clinical development by R-Pharm and currently in Phase III for Sarcoidosis. According to GlobalData, Phase III drugs...
Olokizumab by R-Pharm for Interstitial Lung Diseases (Diffuse Parenchymal Lung Disease): Likelihood of Approval
Olokizumab is under clinical development by R-Pharm and currently in Phase III for Interstitial Lung Diseases (Diffuse Parenchymal Lung Disease)....
Olokizumab by R-Pharm for Idiopathic Interstitial Pneumonia (IIP): Likelihood of Approval
Olokizumab is under clinical development by R-Pharm and currently in Phase III for Idiopathic Interstitial Pneumonia (IIP). According to GlobalData,...